Novel targeted bladder drug-delivery systems: a review

References

• TorchilinVPDrug targetingEur J Pharm Sci200011Suppl 2S81S9111033430
   PubMed Web of Science ®Google Scholar
• NirmalJChuangYCTyagiPChancellorMBIntravesical therapy for lower urinary tract symptomsUrol Sci2012237077
   Google Scholar
• ButteKMominMKurhadeSKarSIntravesical drug delivery system for bladder: an overviewInt J Pharm Chem Biol Sci201333680691
   Google Scholar
• CimaMJLeeHDanielKSingle compartment drug deliveryJ Control Release20142819015717124798478
   PubMed Web of Science ®Google Scholar
• LewisSAEverything you wanted to know about the bladder epithelium but were afraid to askAm J Physiol Renal Physiol20002786867874
   Web of Science ®Google Scholar
• LewisSAThe mammalian urinary bladder: it’s more than accomodatingNews Physiol Sci198616165
   Google Scholar
• BoenMPahnerIAhnert-HilgerGJonsTThe mantainance of the permeability barrier of bladder facet cells requires a continuous fusion of discoid vesicles with the apical plasma membraneEur J Cell Biol20038234335012924629
   PubMed Web of Science ®Google Scholar
• HurstREStructure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tractWorld J Urol19941213108012413
   PubMed Web of Science ®Google Scholar
• TyagiPWuPCChancellorMYoshimuraNHuangLRecent advances in intravesical drug/gene deliveryMol Pharm20063436937916889430
   PubMed Web of Science ®Google Scholar
• AbramsPCardozoLFallMStandardisation Sub-committee of the International Continence SocietyThe standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence societyNeurourol Urodyn20022116717811857671
   PubMed Web of Science ®Google Scholar
• BennerJSNicholMBRovnerESPatient-reported reasons for discontinuing overactive bladder medicationBJU Int20101051276128219912188
   PubMed Web of Science ®Google Scholar
• SchwantesUGrosseJWiedemannARefractory overactive bladder: a common problem?Int Urogynecol J201526101407141425792353
   PubMed Web of Science ®Google Scholar
• ZaccheMMGiarenisICardozoLPhase II drugs that target cholinergic receptors for the treatment of overactive bladderExpert Opin Investig Drugs2014231013651374
   PubMed Web of Science ®Google Scholar
• McLennanMTInterstitial cystitis: epidemiology, pathophysiology, and clinical presentationObstet Gynecol Clin North Am201441338539525155120
   PubMed Web of Science ®Google Scholar
• ParsonsCLThe role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatis/urethritisUrology2007694 Suppl91617462486
   PubMed Web of Science ®Google Scholar
• TsengLHAdvances in the methods for discovering novel painful bladder syndrome therapiesExpert Opin Drug Discov20149442343224606198
   PubMed Web of Science ®Google Scholar
• NICE guidelineBladder Cancer: Diagnosis and ManagementNICE guideline2015 Available from: https://www.nice.org.uk/guidance/ng2Accessed June 6, 2015
   Google Scholar
• ColombelMSolowayMAkazaHEpidemiology, staging, grading, and risk stratification of bladder cancerEur Urol Suppl20087618626
   Web of Science ®Google Scholar
• ParkinDMTobacco-attributable cancer burden in the UK in 2010Br J Cancer2011105Suppl 2S6S1322158323
   PubMed Web of Science ®Google Scholar
• ParkinDMCancers attributable to occupational exposures in the UK in 2010Br J Cancer2011105S70S7222158325
   PubMed Web of Science ®Google Scholar
• HootonTMRecurrent urinary tract infection in womenInt J Antimicrob Agents200117425926811295405
   PubMed Web of Science ®Google Scholar
• AlbertXHuertasIPereiróIISanfélixJGosalbesVPerrotaCAntibiotics for preventing recurrent urinary tract infection in non-pregnant womenCochrane Database Syst Rev20043CD00120915266443
   PubMedGoogle Scholar
• HunstadDAJusticeSSIntracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coliAnnu Rev Microbiol20106420322120825346
   PubMed Web of Science ®Google Scholar
• JirscheleKSandPKOxybutynin: past, present, and futureInt Urogynecol J2013244585604
   Web of Science ®Google Scholar
• HughesKMLangJCLazareRMeasurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteersXenobiotica1992228598691455904
   PubMed Web of Science ®Google Scholar
• SathyanGChancellorMBGuptaSKEffect of OROS® controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chlorideBr J Clin Pharmacol20015240941711678784
   PubMed Web of Science ®Google Scholar
• DavilaGWDaughertyCASandersSWA short term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinenceJ Urol200116614014511435842
   PubMed Web of Science ®Google Scholar
• StaskinDRRobinsonDOxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladderExpert Opin Pharmacother2009103103311119954278
   PubMed Web of Science ®Google Scholar
• PizziLTTalatiAGemmenEDahlNVBunzTJSandPKImpact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX studyPharmacoeconomics20092732933919485428
   PubMed Web of Science ®Google Scholar
• GoldfischerERSandPKThomasHPeters-GeeJEfficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled studyNeurourol Urodyn2015341374324133005
   PubMed Web of Science ®Google Scholar
• GittelmanMWeissHSeidmanLA phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in womenJ Urol201419141014102124231837
   PubMed Web of Science ®Google Scholar
• SwierzewskiMSeidmanLDasenSWeissHPhase 3 Efficacy and safety of once-monthly oxybutynin vaginal ring delivering 4 mg/day or 6 mg/day vs placebo ring in women with urge incontinence, frequency, and urgency symptoms of overactive bladder [abstract 565]108th Annual Meeting of the American Urological Association; May 4–8San Diego, CA2013
   Google Scholar
• KrausePFuhrUSchnitkerJAlbrechtUSteinRRubenwolfPPharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical studyJ Urol201319051791179723669567
   PubMed Web of Science ®Google Scholar
• ColacoMAEvansRJCurrent recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndromeCurr Urol Rep20131444244724101384
   PubMed Web of Science ®Google Scholar
• NeuhausJSchwalenbergTIntravesical treatment of bladder pain syndrome/interstitial cystitisNat Rev Urol2012970772023183946
   PubMed Web of Science ®Google Scholar
• LaiMCKuoYCKuoHCIntravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimensInt J Urol20132020320722925498
   PubMed Web of Science ®Google Scholar
• DahaLKRiedlCRLazarDHohlbruggerGPflugerHDo cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?Eur Urol20054739339715716206
   PubMed Web of Science ®Google Scholar
• RooneyPSrivastavaAWatsonLQuinlanLRPanditAHyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitisActa Biomater201519667525818949
   PubMed Web of Science ®Google Scholar
• KuoYCKuoHCBotulinum toxin injection for lower urinary tract dysfunctionInt J Urol2013201405522571329
   PubMed Web of Science ®Google Scholar
• ColomboRSaloniaALeibZPavone-MacalusoMEngelsteinDLong-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)BJU Int201110791291821029314
   PubMed Web of Science ®Google Scholar
• ParkNNanotechnology: what it can do for drug deliveryJ Control Release20071201317532520
   PubMed Web of Science ®Google Scholar
• HarringtonDASharmaAKEricksonBAChengEYBladder tissue engineering through nanotechnologyWorld J Urol200826431532218536880
   PubMed Web of Science ®Google Scholar
• KumariAYadavSKYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces201075111819782542
   PubMed Web of Science ®Google Scholar
• SinghRLillardJWJrNanoparticle-based targeted deliveryExp Mol Pathol200986321522319186176
   PubMed Web of Science ®Google Scholar
• RajaganapathyBRChancellorMBNirmalJDangLTyagiPBladder uptake of liposomes after intravesical administration occurs by endocytosisPLoS One2015103e012276625811468
   PubMed Web of Science ®Google Scholar
• FraserMOChuangYCTyagiPIntravesical liposome administration-a novel treatment for hyperactive bladder in the ratUrology200361365666312639679
   PubMed Web of Science ®Google Scholar
• ChuangYCLeeWCLeeWCChiangPHIntravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndromeJ Urol200918241393140019683290
   PubMed Web of Science ®Google Scholar
• LanderEBSeeJRIntravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitisAm J Clin Exp Urol20142214514825374916
   PubMedGoogle Scholar
• HaleyBFrenkelENanoparticles for drug delivery in cancer treatmentUrol Oncol2008261576418190833
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov Available from: http://www.clinicaltrials.gov/show/NCT00826085Last Accessed July 26, 2015
   Google Scholar
• GuhaSarkarSBanerjeeRIntravesical drug delivery: challenges, current status, opportunities and novel strategiesJ Control Release2010148214715920831887
   PubMed Web of Science ®Google Scholar
• GongCQiTWeiXThermosensitive polymeric hydrogels as drug delivery systemsCurr Med Chem2013201799423092130
   PubMed Web of Science ®Google Scholar
• TyagiPLiZChancellorMDe GroatWCYoshimuraNHuangLSustained intravesical drug delivery using thermosensitive hydrogelPharm Res20042183283715180342
   PubMed Web of Science ®Google Scholar
• JeongBBaeYHKimSWIn situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereofJ Biomed Mater Res200050217117710679681
   PubMed Web of Science ®Google Scholar
• StavKVinshtokYJeshurunMIvgy-MayNGerassiTZismanASafety and feasibility of intravesical instillation of botulinum toxin in hydrogel-based slow release delivery system in PBS/IC patients: a pilot study [abstract 163]44th Annual Meeting of the International Continence SocietyOctober 20–24Rio de Janeiro, Brazil2014
   Google Scholar
• Available from: http://theracoat.com/clinical-trials/Last Accessed Jul 26, 2015
   Google Scholar
• ClinicalTrials.gov Available from: http://www.clinicaltrials.gov/show/NCT01803295Last Accessed July 26, 2015
   Google Scholar
• LuSNeohKGKangETMahendranRChiongEMucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapyEur J Pharm Sci201572576925772330
   PubMed Web of Science ®Google Scholar
• TobiasISLeeHEngelmayrGCMacayaDBettingerCJCimaMJZero-order controlled release of ciprofloxacin-HCl from a reservoir-based, bioresorbable and elastomeric deviceJ Control Release2010145335636220566343
   PubMed Web of Science ®Google Scholar
• Von WalterMMichaelisIJakseGGrosseJOTrospium chloride released from intravesically applied PLGA-based carriers decreases bladder contractility in an insolated whole pig bladder modelEur Urol Suppl20098178
   Web of Science ®Google Scholar
• HauptMThommesMHeidenreichABreitkreutzJLipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladderJ Control Release201317016116623732944
   PubMed Web of Science ®Google Scholar
• FraserMOLavelleJPSacksMSChancellorMBThe future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapyRev Urol2002411116985646
   PubMedGoogle Scholar
• LeeHCimaMJAn intravesical device for the sustained delivery of lidocaine to the bladderJ Control Release201114913313920971144
   PubMed Web of Science ®Google Scholar
• NickelJCJainPShoreNContinuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery deviceSci Transl Med20124143143ra100
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov Available from: http://www.clinicaltrials.gov/show/NCT02395042Last Accessed July 26, 2015
   Google Scholar
• ClinicalTrials.gov Available from: http://www.clinicaltrials.gov/show/NCT02411110Last Accessed July 26, 2015
   Google Scholar
• LabbafSHorsleyHChangMWAn encapsulated drug delivery system for recalcitrant urinary tract infectionJ R Soc Interface201310892013074724068180
   PubMed Web of Science ®Google Scholar
• LabbafSGhanbarHStrideEEdirisingheMPreparation of multilayered polymeric structures using a novel four-needle coaxial electrohydrodynamic deviceMacromol Rapid Commun201435661862324510905
   PubMed Web of Science ®Google Scholar
• AbbasiFMirzadehHKaybabAModification of polysiloxane polymers for biomedical applications: a reviewPolym Int20015012791287
   Web of Science ®Google Scholar
• PongRCRoarkROuJYMechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical applicationCancer Res200666178822882816951199
   PubMed Web of Science ®Google Scholar
• YamashitaMRosserCJZhouJHSyn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancerCancer Gene Ther20029868769112136430
   PubMed Web of Science ®Google Scholar
• ConnorRJEnglerHMachemerTIdentification of polyamides that enhance adenovirus-mediated gene expression in the urotheliumGene Ther20018414811402300
   PubMed Web of Science ®Google Scholar
• RatliffTLIdentification of pretreatment agents to enhance adenovirus infection of bladder epitheliumJ Urol20051732198219915879887
   PubMedGoogle Scholar
• HorinagaMHarschKMFukuyamaRHestonWLarchianWIntravesical interleukin-12 gene therapy in an orthotopic bladder cancer modelUrology200566246146616040105
   PubMed Web of Science ®Google Scholar
• NogawaMYuasaTKimuraSIntravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancerJ Clin Invest2015115497898515761500
   PubMed Web of Science ®Google Scholar
• MajimaTFunahashiYTakaiSHerpes simplex virus vector-mediated gene delivery of poreless TRPV1 channels reduces bladder overactivity and nociception in ratsHum Gene Ther Epub2015831
   Web of Science ®Google Scholar
• CartwrightRKirbyACTikkinenKASystematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in womenAm J Obstet Gynecol20152122199e1e2425111588
   PubMed Web of Science ®Google Scholar